Clinical Trial: Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy

U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT04846673) titled 'Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy' on April 13.

Brief Summary: This study is a randomized, parallel, open-label, multicenter, phase IV clinical trial to assess the efficacy and safety of pregabalin and alpha-lipoic acid combination compared with each monotherapy in patients with diabetic peripheral neuropathy for 12 weeks.

Study Type: Interventional

Condition: Diabetic Peripheral Neuropathy

Intervention: * Drug: Pregabalin 150mg + Alpha-lipoic acid 480mg

Pregabalin qd + alpha-lipoic acid qd

* Drug: Pregabalin 150mg

pregabalin qd

* Drug: Alpha-...